Debt to Equity Ratio Chart

View Debt to Equity Ratio for SDEV.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Debt to Equity Ratio Chart
Start Trial

Historical Debt to Equity Ratio Data

View and export this data back to 2007. Start Trial.
Date Value
June 30, 2026 0.00
March 31, 2026 0.0046
September 30, 2025 0.5936
June 30, 2025 0.2455
March 31, 2025 0.1824
December 31, 2024 -12.96
September 30, 2024 1.177
June 30, 2024 -3.258
March 31, 2024 15.14
December 31, 2023 0.7885
September 30, 2023 0.4262
June 30, 2023 0.355
March 31, 2023 0.2225
December 31, 2022 0.1934
September 30, 2022 0.1566
June 30, 2022 0.1442
March 31, 2022 0.1345
December 31, 2021 0.0542
September 30, 2021 0.0209
June 30, 2021 0.027
March 31, 2021 0.0369
December 31, 2020 0.0408
September 30, 2020 0.0505
June 30, 2020 1.469
March 31, 2020 -9.696
Date Value
December 31, 2019 4.158
September 30, 2019 1.818
June 30, 2019 2.827
March 31, 2019 3.952
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 -0.2124
March 31, 2016 -0.4196
December 31, 2015 -0.3246
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00
December 31, 2013 0.00

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

View Debt to Equity Ratio Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

View Debt to Equity Ratio Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 1.022
Corcept Therapeutics, Inc. 0.0133
Veru, Inc. 0.0945
Johnson & Johnson 0.5771
Eli Lilly & Co. 1.621